Methylation related genes are associated with prognosis of patients with head and neck squamous cell carcinoma via altering tumor immune microenvironment
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Methylation related genes are associated with prognosis of patients with head and neck squamous cell carcinoma via altering tumor immune microenvironment
Authors
Keywords
-
Journal
Journal of Dental Sciences
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2022-08-05
DOI
10.1016/j.jds.2022.07.010
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- miR-381 Mediates the Development of Head and Neck Squamous Cell Carcinoma via Targeting STC2
- (2020) Hai-Feng Ma et al. OncoTargets and Therapy
- Epigenetic Alterations Associated with the Overall Survival and Recurrence Free Survival among Oral Squamous Cell Carcinoma Patients
- (2020) Yasmen Ghantous et al. Journal of Clinical Medicine
- DNA Methylome Distinguishes Head and Neck Cancer from Potentially Malignant Oral Lesions and Healthy Oral Mucosa
- (2020) Nina Milutin Gašperov et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Pre-Operative Evaluation of DNA Methylation Profile in Oral Squamous Cell Carcinoma Can Predict Tumor Aggressive Potential
- (2020) Davide Gissi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- TIGIT in cancer immunotherapy
- (2020) Joe-Marc Chauvin et al. Journal for ImmunoTherapy of Cancer
- Identification of PLOD Family Genes as Novel Prognostic Biomarkers for Hepatocellular Carcinoma
- (2020) Bo Yang et al. Frontiers in Oncology
- The effect of a novel glycolysis-related gene signature on progression, prognosis and immune microenvironment of renal cell carcinoma
- (2020) Fangshi Xu et al. BMC CANCER
- Tumor microenvironment and Oral Squamous Cell Carcinoma: A crosstalk between the inflammatory state and tumor cell migration
- (2020) Alessandro Alves et al. ORAL ONCOLOGY
- Clinicopathological and Prognostic Significance of PRAME Overexpression in Human Cancer: A Meta-Analysis
- (2020) Jiaqiang Li et al. Biomed Research International
- Cancer Testis Antigens and Immunotherapy: Expression of PRAME Is Associated with Prognosis in Soft Tissue Sarcoma
- (2020) Markus Albertsmeier et al. Cancers
- Systematic analysis of differentially methylated expressed genes and site‐specific methylation as potential prognostic markers in head and neck cancer
- (2019) Guohui Bai et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Immune microenvironment and expression of PD-L1, PD-1, cancer testis antigen PRAME and MHC I in salivary duct carcinoma
- (2019) Bin Xu et al. HISTOPATHOLOGY
- Analysis of methylation‐driven genes for predicting the prognosis of patients with head and neck squamous cell carcinoma
- (2019) Yihua Pan et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- E-cadherin is required for metastasis in multiple models of breast cancer
- (2019) Veena Padmanaban et al. NATURE
- Cancer statistics, 2018
- (2018) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Understanding the tumor immune microenvironment (TIME) for effective therapy
- (2018) Mikhail Binnewies et al. NATURE MEDICINE
- Epigenome-based cancer risk prediction: rationale, opportunities and challenges
- (2018) Martin Widschwendter et al. Nature Reviews Clinical Oncology
- Cancer immunotherapy using checkpoint blockade
- (2018) Antoni Ribas et al. SCIENCE
- Head and Neck Cancer Survivorship: Learning the Needs, Meeting the Needs
- (2018) Jolie Ringash et al. SEMINARS IN RADIATION ONCOLOGY
- The DNA methylation landscape of glioblastoma disease progression shows extensive heterogeneity in time and space
- (2018) Johanna Klughammer et al. NATURE MEDICINE
- Acyl-CoA dehydrogenase long chain expression is associated with esophageal squamous cell carcinoma progression and poor prognosis
- (2018) Dong-lin Yu et al. OncoTargets and Therapy
- Serum, plasma and saliva biomarkers for head and neck cancer
- (2017) Lidia Maria Rebolho Batista Arantes et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- Tim-3 and its role in regulating anti-tumor immunity
- (2017) Madhumita Das et al. IMMUNOLOGICAL REVIEWS
- LAG3 (CD223) as a cancer immunotherapy target
- (2017) Lawrence P. Andrews et al. IMMUNOLOGICAL REVIEWS
- Dectin 1 activation on macrophages by galectin 9 promotes pancreatic carcinoma and peritumoral immune tolerance
- (2017) Donnele Daley et al. NATURE MEDICINE
- Statistical and integrative system-level analysis of DNA methylation data
- (2017) Andrew E. Teschendorff et al. NATURE REVIEWS GENETICS
- T-cell Receptor Signaling Activates an ITK/NF-κB/GATA-3 axis in T-cell Lymphomas Facilitating Resistance to Chemotherapy
- (2016) Tianjiao Wang et al. CLINICAL CANCER RESEARCH
- DNA methylation-based prognosis and epidrivers in hepatocellular carcinoma
- (2015) Augusto Villanueva et al. HEPATOLOGY
- Robust enumeration of cell subsets from tissue expression profiles
- (2015) Aaron M Newman et al. NATURE METHODS
- LIMD2 Is a Small LIM-Only Protein Overexpressed in Metastatic Lesions That Regulates Cell Motility and Tumor Progression by Directly Binding to and Activating the Integrin-Linked Kinase
- (2014) H. Peng et al. CANCER RESEARCH
- Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
- (2012) Douglas Hanahan et al. CANCER CELL
- Cancer Genetics and Epigenetics: Two Sides of the Same Coin?
- (2012) Jueng Soo You et al. CANCER CELL
- Delineating an epigenetic continuum in head and neck cancer
- (2012) Maria J. Worsham et al. CANCER LETTERS
- Peripheral blood DNA methylation profiles are indicative of head and neck squamous cell carcinoma: An epigenome-wide association study
- (2012) Scott M. Langevin et al. Epigenetics
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started